Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,853 | 869 | 99.6% |
| Education | $56.84 | 7 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,946 | 114 | $0 (2022) |
| PFIZER INC. | $1,276 | 134 | $0 (2022) |
| ABBVIE INC. | $1,190 | 72 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,053 | 58 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $981.63 | 68 | $0 (2022) |
| GlaxoSmithKline, LLC. | $805.44 | 58 | $0 (2022) |
| Lilly USA, LLC | $520.63 | 32 | $0 (2022) |
| Merck Sharp & Dohme LLC | $433.40 | 72 | $0 (2022) |
| Novo Nordisk Inc | $409.40 | 32 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $393.53 | 23 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.12 | 1 | ABBVIE INC. ($18.12) |
| 2023 | $91.79 | 4 | NESTLE HEALTHCARE NUTRITION INC. ($60.30) |
| 2022 | $1,264 | 71 | ABBVIE INC. ($252.73) |
| 2021 | $3,198 | 193 | AbbVie Inc. ($516.73) |
| 2020 | $1,053 | 65 | AstraZeneca Pharmaceuticals LP ($320.33) |
| 2019 | $3,162 | 226 | AstraZeneca Pharmaceuticals LP ($422.79) |
| 2018 | $3,063 | 238 | AstraZeneca Pharmaceuticals LP ($553.42) |
| 2017 | $1,060 | 78 | AstraZeneca Pharmaceuticals LP ($174.28) |
All Payment Transactions
876 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/22/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/09/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/08/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $30.89 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/19/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/13/2022 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $10.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/26/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/27/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $31.61 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/24/2022 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/17/2022 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Oncology | ||||||
| 05/13/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/30/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/27/2022 | MorphoSys, US Inc. | MONJUVI (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Oncology | ||||||
| 04/26/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Diabetes | ||||||
| 04/22/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Cardio-renal | ||||||
| 04/19/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Cardiovascular | ||||||
| 04/19/2022 | Amgen Inc. | Nplate (Biological), XGEVA | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Hematology | ||||||
| 04/18/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 04/13/2022 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Oncology | ||||||
| 04/12/2022 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | Cash or cash equivalent | $20.88 | General |
| Category: Oncology | ||||||
| 04/12/2022 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $13.54 | General |
| Category: Opioid Analgesic | ||||||
| 04/11/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 376 | 479 | $96,214 | $33,147 |
| 2022 | 9 | 414 | 544 | $101,046 | $40,742 |
| 2021 | 13 | 751 | 985 | $159,605 | $72,752 |
| 2020 | 13 | 702 | 888 | $148,407 | $58,026 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 112 | 170 | $43,232 | $13,204 | 30.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 101 | 101 | $29,716 | $11,693 | 39.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 79 | 124 | $20,234 | $7,065 | 34.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 28 | 28 | $1,834 | $878.36 | 47.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 17 | $918.00 | $188.16 | 20.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 11 | 11 | $266.00 | $104.72 | 39.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 28 | 28 | $14.00 | $13.72 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 124 | 189 | $46,494 | $16,682 | 35.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 88 | 88 | $23,147 | $11,937 | 51.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 90 | 146 | $23,016 | $8,772 | 38.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 15 | 15 | $2,640 | $1,317 | 49.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 26 | 30 | $3,262 | $1,027 | 31.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 26 | 26 | $1,378 | $796.48 | 57.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 16 | 18 | $809.00 | $154.82 | 19.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 13 | 16 | $292.00 | $47.22 | 16.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 16 | 16 | $8.00 | $7.84 | 98.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 150 | 150 | $36,450 | $20,691 | 56.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 115 | 177 | $39,648 | $16,475 | 41.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 146 | 236 | $35,636 | $14,393 | 40.4% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 102 | 102 | $17,952 | $8,549 | 47.6% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 16 | 19 | $9,139 | $4,423 | 48.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 43 | 68 | $6,188 | $2,823 | 45.6% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 13 | 15 | $5,145 | $2,436 | 47.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 50 | 50 | $2,650 | $886.50 | 33.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 18 | 20 | $2,240 | $883.20 | 39.4% |
About Dr. John Horan, DO
Dr. John Horan, DO is a Family Medicine healthcare provider based in Warwick, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1679567531.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Horan, DO has received a total of $12,909 in payments from pharmaceutical and medical device companies, with $18.12 received in 2024. These payments were reported across 876 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($12,853).
As a Medicare-enrolled provider, Horan has provided services to 2,243 Medicare beneficiaries, totaling 2,896 services with total Medicare billing of $204,668. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Warwick, RI
- Active Since 09/07/2005
- Last Updated 03/07/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679567531
Products in Payments
- FARXIGA (Drug) $945.81
- XARELTO (Drug) $938.60
- ELIQUIS (Drug) $666.13
- CHANTIX (Drug) $585.02
- TRELEGY ELLIPTA (Drug) $503.12
- UBRELVY (Drug) $446.01
- JARDIANCE (Drug) $430.88
- STIOLTO RESPIMAT (Drug) $382.39
- TRULICITY (Drug) $334.83
- SYMBICORT (Drug) $288.52
- XIFAXAN (Drug) $278.01
- LINZESS (Drug) $252.24
- JANUVIA (Drug) $251.21
- ZENPEP (Drug) $247.29
- BEVESPI AEROSPHERE (Drug) $240.83
- Creon (Drug) $226.48
- Vascepa (Drug) $194.95
- MYRBETRIQ (Drug) $191.46
- TRADJENTA (Drug) $174.98
- Ozempic (Drug) $170.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Warwick
Martin Kerzer, Do, DO
Family Medicine — Payments: $17,316
Carol Taylor, M.d, M.D
Family Medicine — Payments: $13,577
Dr. Michael Rekas, D.o, D.O
Family Medicine — Payments: $12,250
Gregory Steinmetz, Md, MD
Family Medicine — Payments: $8,706
David Coia, Do, DO
Family Medicine — Payments: $6,828
Keith Callahan, M.d, M.D
Family Medicine — Payments: $6,226